Moderna MRNA has outperformed the market over the past 5 years by 12.29% on an annualized basis producing an average annual return of 25.34%. Currently, Moderna has a market capitalization of $20.80 billion.

Buying $100 In MRNA: If an investor had bought $100 of MRNA stock 5 years ago, it would be worth $309.19 today based on a price of $54.11 for MRNA at the time of writing.

Moderna's Performance Over Last 5 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs